MARS study

  • Research type

    Research Study

  • Full title

    Mesh Augmented Reinforcement of Abdominal Wall Suture Line in Patients Undergoing Midline Laparotomy to Limit the Rate of Incisional Hernia (IH) Occurrence

  • IRAS ID

    314752

  • Contact name

    Dale Vimalachandran

  • Contact email

    dale.vimalachandran@nhs.net

  • Sponsor organisation

    Sofradim Production S.A.S.U,

  • Clinicaltrials.gov Identifier

    NCT05424484

  • Duration of Study in the UK

    4 years, 7 months, 26 days

  • Research summary

    The purpose of this prospective, pivotal, multi-center, single-arm cohort, pre-market, investigational clinical study is to assess the safety and performance of Deternia™ Self-Gripping Resorbable Mesh when used for suture line reinforcement after midline laparotomy in clean and clean-contaminated fields (CDC Classification I and II). Data from this study will be used to support market applications. A laparotomy is a planned open surgery performed by a midline incision (cut) at the abdominal cavity (belly). The study mesh is intended to be used for the reinforcement of abdominal wall soft tissues where weakness exists in procedures involving abdominal suture line reinforcement. It is designed to provide strength and tissue integration throughout the critical healing period. It is composed by fully resorbable materials which are completely resorbed in 3 to 5 years post-implantation and it has absorbable grips on one side to hold the mesh in contact with the tissue.

  • REC name

    North West - Greater Manchester East Research Ethics Committee

  • REC reference

    22/NW/0158

  • Date of REC Opinion

    6 Sep 2022

  • REC opinion

    Further Information Favourable Opinion